The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Refinement of metabolite detection in cystic fibrosis sputum reveals heme correlates with lung function decline
Published version of a preprint
Abstract
The bacterial growth environment within cystic fibrosis (CF) sputum is complex, dynamic, and shaped by both host and microbial processes. Characterization of the chemical parameters within sputum that stimulate the in vivo growth of airway pathogens (e.g. Pseudomonas aeruginosa) and their associated virulence factors may lead to improved CF treatment strategies. Motivated by conflicting reports of the prevalence and abundance of P. aeruginosa-derived metabolites known as phenazines within CF airway secretions, we sought to quantify these metabolites in sputum using quadrupole time-of-flight mass spectrometry. In contrast to our previous work, all phenazines tested (pyocyanin (PYO), phenazine-1-carboxylic acid (PCA), phenazine-1-carboxamide, and 1-hydroxyphenazine) were below detection limits of the instrument (0.1 μM). Instead, we identified a late-eluting compound that shared retention time and absorbance characteristics with PCA, yet generated mass spectra and a fragmentation pattern consistent with ferriprotoporphyrin IX, otherwise known as heme B. These data suggested that UV-vis chromatographic peaks previously attributed to PCA and PYO in sputum were mis-assigned. Indeed, retrospective analysis of raw data from our prior study found that the heme B peak closely matched the peaks assigned to PCA, indicating that the previous study likely uncovered a positive correlation between pulmonary function (percent predicted forced expiratory volume in 1 second, or ppFEV1) and heme B, not PCA or any other phenazine. To independently test this observation, we performed a new tandem mass-spectrometry analysis of 71 additional samples provided by the Mountain West CF Consortium Sputum Biomarker study and revealed a positive correlation (ρ = -0.47, p<0.001) between sputum heme concentrations and ppFEV1. Given that hemoptysis is strongly associated with airway inflammation, pulmonary exacerbations and impaired lung function, these new data suggest that heme B may be a useful biomarker of CF pathophysiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A recent study indicated that heme levels in the CF lung negatively correlate with lung function (60).”
From Heme protects Pseudomonas aeruginosa and Staphylococcus aureus from calprotectin-induced iron starvation (2021) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Predictive 5-year survivorship model of cystic fibrosis
Liou, T. G., Adler, F. R., FitzSimmons, S. C., Cahill, B. C., Hibbs, J. R., & Marshall, B. C. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.4.345 · Cited by 749
Self-citationWilson, R., Sykes, D. A., Watson, D., Rutman, A., Taylor, G. W., & Cole, P. J. (1988) · Infection and Immunity · doi:10.1128/iai.56.9.2515-2517.1988 · Cited by 374 · cited 1×
“Several independent analyses have detected phenazines in sputum from CF patients [4, 5].”
BackgroundMassive hemoptysis in cystic fibrosis
Flume, P. A., Yankaskas, J. R., Ebeling, M., Hulsey, T., & Clark, L. L. (2005) · Chest · doi:10.1378/chest.128.2.729 · Cited by 215
Research works printed but not linked: 22
- F Harrison, 2007, Microbial ecology of the cystic fibrosis lung, Microbiol, 153, 917, 10.1099/mic.0.2006/004077-0 · DOI · Paper page
- SD Aaron, 2015, A statistical model to predict one-year risk of death in patients with cystic fibrosis, J Clin Epidemiol, 68, 1336, 10.1016/j.jclinepi.2014.12.010 · DOI
- GW Lau, 2004, Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice, Infect Immunity, 72, 4275, 10.1128/IAI.72.7.4275-4278.2004 · DOI · Paper page
- RA Quinn, 2015, Microbial, host and xenobiotic diversity in the cystic fibrosis sputum metabolome, ISME J, 10, 1483, 10.1038/ismej.2015.207 · DOI
- RC Hunter, 2012, Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity, Am J Resp Cell Mol Biol, 47, 738, 10.1165/rcmb.2012-0088OC · DOI · Paper page
- TG Liou, 2019, Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis, BMC Med Res Method, 19, 88, 10.1186/s12874-019-0705-0 · DOI
- DB Rubin, 1976, Inference and missing data, Biometrika, 64, 581, 10.1093/biomet/63.3.581 · DOI · Paper page
- S Létoffé, 2009, Bacteria capture iron from heme by keeping tetrapyrrol skeleton intact, Proc Nat Acad Sci USA, 106, 11719, 10.1073/pnas.0903842106 · DOI
- DB Morrison, 1941, The solubility and titration of hemin and ferrihemic acid, J Biol Chem, 137, 461, 10.1016/S0021-9258(19)56151-8 · doi:10.1016/s0021-9258(19)56151-8
- P Jorth, 2015, Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis Lungs, Cell Host Microb, 18, 307, 10.1016/j.chom.2015.07.006 · DOI · Paper page
- ES Cowley, 2015, Pediatric cystic fibrosis sputum can be chemically dynamic, anoxic, and extremely reduced due to hydrogen sulfide formation, mBio, 6, e00767, 10.1128/mBio.00767-15 · DOI · Paper page
- HJ Fuchs, 1994, Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis, N Engl J Med, 331, 637, 10.1056/NEJM199409083311003 · DOI · Paper page
- T Das, 2015, Phenazine virulence factor binding to extracellular DNA is important for Pseudomonas aeruginosa biofilm formation, Sci Rep, 5, 8398, 10.1038/srep08398 · DOI · Paper page
- HR Rabin, 2004, Pulmonary exacerbations in cystic fibrosis, Ped Pulmonol, 37, 400, 10.1002/ppul.20023 · DOI · Paper page
- JU Barben, 2003, Major haemoptysis in children with cystic fibrosis: a 20-year retrospective study, J Cyst Fib, 2, 105, 10.1016/S1569-1993(03)00066-3 · DOI
- RC Hunter, 2013, Ferrous iron is a significant component of bioavailable iron in cystic fibrosis airways, mBio, 4, e00557, 10.1128/mBio.00557-13 · DOI · Paper page
- E Banin, 2005, Iron and Pseudomonas aeruginosa biofilm formation, Proc Nat Acad Sci USA, 102, 11076, 10.1073/pnas.0504266102 · DOI · Paper page
- S Moreau-Marquis, 2009, Tobramycin and FDA-Approved Iron Chelators Eliminate Pseudomonas aeruginosa Biofilms on Cystic Fibrosis Cells, Am J Resp Cell Mol Biol, 41, 305, 10.1165/rcmb.2008-0299OC · DOI · Paper page
- 2018, Cystic Fibrosis Foundation Patient Registry 2017 Annual Data Report
- M Matsumoto, 1998, Mersenne Twister: A 623-dimensionally Equidistributed Uniform Pseudo-random Number Generator, ACM Trans Model Comput Simul, 8, 3, 10.1145/272991.272995 · DOI · Paper page
- Standardization of Spirometry, 1994 Update, 1995, American Thoracic Society, Am J Resp Crit Care Med, 152, 1107
- JL Hankinson, 1999, Spirometric reference values from a sample of the general U.S. population, Am J Resp Crit Care Med, 159, 179, 10.1164/ajrccm.159.1.9712108 · DOI · Paper page
Cited by
Zygiel, E. M., Obisesan, A. O., Nelson, C. E., Oglesby, A. G., & Nolan, E. M. (2021) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015975 · Cited by 36
Metadata
- Authors
- Glasser, N. R., Hunter, R. C., Liou, T. G., Newman, D. K., & for the Mountain West CF Consortium Investigators
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-12-18
- Volume
- 14
- Issue
- 12
- Pages
- e0226578
- ISSN
- 1932-6203
- Cited by
- 22
- References
- 3
- Language
- en
- Funders
- Cystic Fibrosis Foundation (LIOU13A0, LIOU14Y4)
- National Center for Advancing Translational Sciences (NIH 8UL1TR000105)
- Ben B. and Iris M. Margolis Foundation
- National Heart, Lung, and Blood Institute (R01HL117328)
- National Institute of Allergy and Infectious Diseases (R01AI127850)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.